The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing

References

• Role of rapid testing during the COVID-19 pandemic [Internet]; 2021 [ cited 2021 Feb 27]. Available from: https://www.mlo-online.com/diagnostics/poct/article/21210731/role-of-rapid-testing-during-the-covid19-pandemic.
   Google Scholar
• HHS statements on authorizing licensed pharmacists to order and administer COVID-19 Tests. 2020 Apr 8. [Internet]; 2020 [ cited 2021 Feb 26]. Available from: https://www.hhs.gov/about/news/2020/04/08/hhs-statements-on-authorizing-licensed-pharmacists-to-order-and-administer-covid-19-tests.html.
   Google Scholar
• Advisory Opinion 20-02 on the public readiness and emergency preparedness act and the secretary’s declaration under the act. 2020 May 19. [Internet]; 2020 [ cited 2021 Feb 26]. Available from: https://www.hhs.gov/sites/default/files/advisory-opinion-20-02-hhs-ogc-prep-act.pdf.
   Google Scholar
• Guidance for licensed pharmacists, COVID-19 testing, and immunity under the PREP Act. 2020 Apr 8 [Internet]; 2020 [ cited 2021 Feb 26]. Available from: https://www.hhs.gov/sites/default/files/authorizing-licensed-pharmacists-to-order-and-administer-covid-19-tests.pdf.
   Google Scholar
• Gubbins PO, Klepser ME, Adams AJ, et al. Potential for Pharmacy–public health collaborations using pharmacy-based point-of-care testing services for infectious diseases. J Public Health Manag Pract. 2017 December 01;23(6):593–600.
   PubMed Web of Science ®Google Scholar
• Weber NC, Klepser ME, Akers JM, et al. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States. Expert Rev Mol Diagn. 2016;16(2):253–264.
   PubMed Web of Science ®Google Scholar
• Rosenfeld LA, Etkind P, Grasso A, et al. Extending the reach: local health department collaboration with community pharmacies in Palm Beach County, Florida for H1N1 influenza pandemic response. J Public Health Manag Pract. 2011 October 01;17(5):439–448.
   PubMed Web of Science ®Google Scholar
• Blank C. Pharmacists top most trusted professions in gallup poll. Drug Topics. 2020 January;20.
   Google Scholar
• Akinwale TP, Adams AJ, Dering-Anderson AM, et al. Pharmacy-based point-of-care testing for infectious diseases: considerations for the pharmacy curriculum. Curr Pharm Teach Learn. 2015;7(1):131–136. . Invalid date Invalid date
   Web of Science ®Google Scholar
• Klepser NS, Klepser DG, Adams JL, et al. Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities. Res Social Adm Pharm. 2020 December;15.
   Google Scholar
• Klepser ME, Adams AJ, Srnis P, et al. U.S. community pharmacies as CLIA-waived facilities: prevalence, dispersion, and impact on patient access to testing. Res Social Adm Pharm. 2016 August 01;12(4):614–621.
   PubMed Web of Science ®Google Scholar
• Adams AJ, Klepser ME, Klepser D. An update on community pharmacies as CLIA-waived facilities. Res Social Adm Pharm. 2016 August 01;12(4):666–667.
   PubMed Web of Science ®Google Scholar
• Gubbins PO, Klepser ME, Dering-Anderson AM, et al. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. J Am Pharm Assoc. 2003 April 01 [2003];54(2):163–171. .
   Google Scholar
• Klepser DG, Klepser ME. Point-of-care testing in the pharmacy: how is the field evolving? Expert Rev Mol Diagn. 2018 January 01;18(1):5–6.
   PubMed Web of Science ®Google Scholar
• Klepser M, Adams AJ, Klepser D. Clinical service implementation in the face of initial regulatory uncertainty. J Am Pharm Assoc, 2003.2016. October, 01. 56(5): 492.
   Google Scholar
• Howerton D, Anderson N, Bosse D, et al. Good laboratory practices for waived testing sites: survey findings from testing sites holding a certificate of waiver under the clinical laboratory improvement amendments of 1988 and recommendations for promoting quality testing. MMWR Recomm Rep. 2005 November 11;54(RR–13):1,25; quiz CE1.
   PubMedGoogle Scholar
• Adams A, Weaver K. Pharmacists’ patient care process: a state “scope of practice” perspective. Innovations in Pharmacy. 2019;10(2):7. .
   PubMedGoogle Scholar
• Adams AJ, Weaver KK. Pharmacists’ patient care process: state “scope of practice” priorities for action. Ann Pharmacother. 2021;55(4):549–555. . Invalid date Invalid date
   PubMed Web of Science ®Google Scholar
• Partial Waiver of Off-Site Pharmacy Practice in Response to COVID-19. Published 2020 Mar 17. [Internet]; 2020 [ cited 2021 Feb 26]. Available from: https://bop.nv.gov/uploadedFiles/bopnvgov/content/Resources/ALL/Partial%20Waiver%20for%20Off-Site%20Nasal%20Swab%20Test(1).pdf.
   Google Scholar
• Executive Order 2020-09, executive order 2020-09, State of North Dakota, (2020).
   Google Scholar
• COVID-19 testing update 5/21/2020 [Internet]; 2020 [ cited 2021 Feb 26]. Available from: https://www.wvbop.com/article.asp?action2=showArticle&id=52&ty=CTTS.
   Google Scholar
• COVID-19: information from the States. [Internet]; 2020 [ cited 2021 Feb 26]. Available from: https://naspa.us/resource/covid-19-information-from-the-states/.
   Google Scholar
• Broughel J, Yatsyshina Y Relax pharmacy regulations to help with COVID-19 Testing and Treatment. Policy Brief. Mercatus Center at George Mason University; 2020.
   Google Scholar
• Bacci JL, Coley KC, McGrath K, et al. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies. J Am Pharm Assoc; 2016. 56(3):257,265.e2. Invalid date Invalid date.
   Google Scholar
• Adams AJ. Pharmacist prescriptive authority: lessons from Idaho. Pharmacy. 2020;8(3):112.
   Web of Science ®Google Scholar
• Futrell K. Point-of-care-testing takes center stage to meet demand for COVID-19 diagnostics. MLO. 2020. October 02.
   Google Scholar
• Community-based testing sites for COVID-19 [Internet]; 2021 [ cited 2021 Feb 27]. Available from: https://www.hhs.gov/coronavirus/community-based-testing-sites/index.html
   Google Scholar
• The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic - NCBI Bookshelf [Internet]. [ cited 2021 Mar 15 2021]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK52792/
   Google Scholar
• Steyer TE, Ragucci KR, Pearson WS, et al. The role of pharmacists in the delivery of influenza vaccinations. Vaccine. 2004 February 25;22(8):1001–1006.
   PubMed Web of Science ®Google Scholar
• Early-season flu vaccination coverage–United States, November 2018 [Internet]: Center for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD); Invalid date [updated Invalid date; cited 2021 2021 Mar 15]. Available from: https://www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2018.htm.
   Google Scholar
• Milenkovich N. HHS empowers pharmacists to administer COVID-19 Vaccine, Pharmacy Times. 2020. 88
   Google Scholar
• Nguyen E, Walker K, Adams JL, et al. Reimbursement for pharmacist-provided health care services: a multistate review. J Am Pharm Assoc, 2003. 2021. February, 01. 61(1). 27–32.
   Google Scholar
• Wadsworth TG, Hibbard A, Robinson R, et al. Pharmacist medical provider status in Alaska, the last frontier. J Am Pharm Assoc. 2003 December 01 [];60(6):e47–51. .
   Google Scholar
• Medicare and medicaid programs, basic health program, and exchanges; additional policy and regulatory revisions in response to the COVID-19 public health emergency and delay of certain reporting requirements for the skilled nursing facility quality reporting program, CMS-5531-IFC, (2020).
   Google Scholar
• Medicare pharmacies and other suppliers may temporarily enroll as independent clinical diagnostic laboratories to help address COVID-19 testing [Internet]; 2020 [ cited 2021 Mar 1]. Available from: https://www.cms.gov/files/document/se20017.pdf.
   Google Scholar